Conference Programme
This conference will be supported by grants from Roche Products Limited, Pfizer UK (2nd day only), Takeda Pharmaceuticals, Nuvalent Inc, Guardant Health and the Ruth Strauss Foundation. These companies have had no control over the content of the conference.
Friday 27th September
14.00 Check in and Registration
16.00 Afternoon tea and meet-up
18.30 Drinks reception
19.30 Dinner
21.00 Professor Sanjay Popat: Medical Oncologist, The Royal Marsden Hospital and the Charity’s Honorary Clinical Advisor
Saturday 28th September
08.00 – 09.30 Breakfast
09.30 Day Delegate registration
09.45 Welcome & Introduction
10.00 Dr Fabio Gomes: Medical Oncologist, The Christie Hospital, Manchester: “The ALK Education Project” update.
10.45 Tea/Coffee
11.30 Dr Riyaz Shah: Consultant Medical Oncologist, Kent Oncology: “Circulating tumour DNA”
12.15 Dr Anna Minchom: Medical Oncologist, The Royal Marsden, lead investigator of the Nuvalent Trial and Clinical Scientist, Institute of Cancer Research: “Clinical Trials”
01.00 Lunch
14.00 Ms Karen Clayton: Macmillan Lung/Palliative Clinical Nurse Specialist: “What to expect from your CNS”
14.45 Professor Alastair Greystoke: Medical Oncologist, Northern Centre for Cancer Care: “Local Consolidated Therapy”
15.30 Tea/Coffee
16.15 Dr Shobhit Baijal: Medical Oncologist, University Hospital, Birmingham:
“Questions & Answer Session”
17.00 Close
18.30 Drinks Reception
19.30 Dinner
Sunday 29th September
08.00 – 09.30 Breakfast
10.30 Ms Debra Montague: Chair ALK Positive Lung Cancer UK: “Update from the Charity”
11.00 Tea/Coffee
11.45 Nuvalent, Inc. “The Nuvalent Trial – ALKOVE-1”
12.30 Close & Lunch
09.45 Professor Ben Solomon: Medical Oncologist, Peter MacCallum Cancer Centre, Melbourne, Australia: “Brief history of TKIs and what the future holds for existing patients”
